These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum Disorder. Ringelstein M, Ayzenberg I, Harmel J, Lauenstein AS, Lensch E, Stögbauer F, Hellwig K, Ellrichmann G, Stettner M, Chan A, Hartung HP, Kieseier B, Gold R, Aktas O, Kleiter I. JAMA Neurol; 2015 Jul; 72(7):756-63. PubMed ID: 25985228 [Abstract] [Full Text] [Related]
3. A 5-year follow-up of rituximab treatment in patients with neuromyelitis optica spectrum disorder. Kim SH, Huh SY, Lee SJ, Joung A, Kim HJ. JAMA Neurol; 2013 Sep 01; 70(9):1110-7. PubMed ID: 23897062 [Abstract] [Full Text] [Related]
6. Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients. Jacob A, Weinshenker BG, Violich I, McLinskey N, Krupp L, Fox RJ, Wingerchuk DM, Boggild M, Constantinescu CS, Miller A, De Angelis T, Matiello M, Cree BA. Arch Neurol; 2008 Nov 01; 65(11):1443-8. PubMed ID: 18779415 [Abstract] [Full Text] [Related]
11. Treatment Outcomes With Rituximab in 100 Patients With Neuromyelitis Optica: Influence of FCGR3A Polymorphisms on the Therapeutic Response to Rituximab. Kim SH, Jeong IH, Hyun JW, Joung A, Jo HJ, Hwang SH, Yun S, Joo J, Kim HJ. JAMA Neurol; 2015 Sep 01; 72(9):989-95. PubMed ID: 26167726 [Abstract] [Full Text] [Related]
12. A review of cases of neuromyelitis optica. Bomprezzi R, Postevka E, Campagnolo D, Vollmer TL. Neurologist; 2011 Mar 01; 17(2):98-104. PubMed ID: 21364364 [Abstract] [Full Text] [Related]
14. The Efficacy and Tolerability of Mycophenolate Mofetil in Treating Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder in Western China. Chen H, Zhang Y, Shi Z, Feng H, Yao S, Xie J, Zhou H. Clin Neuropharmacol; 2016 Mar 01; 39(2):81-7. PubMed ID: 26818042 [Abstract] [Full Text] [Related]
16. Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica: a pilot study. Araki M, Matsuoka T, Miyamoto K, Kusunoki S, Okamoto T, Murata M, Miyake S, Aranami T, Yamamura T. Neurology; 2014 Apr 15; 82(15):1302-6. PubMed ID: 24634453 [Abstract] [Full Text] [Related]
17. Comparison of relapse and treatment failure rates among patients with neuromyelitis optica: multicenter study of treatment efficacy. Mealy MA, Wingerchuk DM, Palace J, Greenberg BM, Levy M. JAMA Neurol; 2014 Mar 15; 71(3):324-30. PubMed ID: 24445513 [Abstract] [Full Text] [Related]
18. Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers. Palace J, Leite MI, Nairne A, Vincent A. Arch Neurol; 2010 Aug 15; 67(8):1016-7. PubMed ID: 20697055 [Abstract] [Full Text] [Related]